Tevogen Bio Holdings Inc.·4

Jun 7, 4:29 PM ET

Saadi Ryan H. 4

4 · Tevogen Bio Holdings Inc. · Filed Jun 7, 2024

Insider Transaction Report

Form 4
Period: 2024-06-05
Saadi Ryan H.
DirectorChief Executive Officer10% Owner
Transactions
  • Purchase

    Common Stock

    2024-06-05$0.77/sh+2,607.322$2,000118,252,659.322 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    193,924
Footnotes (1)
  • [F1]The price reported in Column 4 represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7635 to $0.7671, inclusive. The reporting person undertakes to provide to Tevogen Bio Holdings Inc., any security holder of Tevogen Bio Holdings Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES